9 Meters Biopharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of 9 Meters Biopharma generated cash of -$37,243,217, which is less than the previous year. Cash used in financing activities reached the amount of $19,911,706 last year. Net change in cash is therefore -$17,334,353.
Cash Flow
| 2013 | -3.87M | 0 | 3.81M |
|---|---|---|---|
| 2014 | -7.45M | 0 | 7.54M |
| 2015 | -1.73M | 0 | 1.75M |
| 2016 | -8.42M | 0 | 9.76M |
| 2017 | -4.00M | 0 | 2.97M |
| 2018 | -15.16M | -13.94K | 20.55M |
| 2019 | -17.96M | -11.93K | 16.84M |
| 2020 | -19.40M | -3.18M | 55.85M |
| 2021 | -29.47M | -2.43M | 41.05M |
| 2022 | -37.24M | -2.84K | 19.91M |
NMTR Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 46.99M | 37.85M | 4.59M | 5.72M | 355.56K | 1.45M | 119K | 97K | 1K | 62K |
Operating activities | ||||||||||
Net income | -43.76M | -36.77M | -61.49M | -27.04M | -24.16M | -7.92M | -6.21M | -8.74M | -11.05M | -3.43M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 8.52K | 7.57K | 18.49K | 21.60K | 19.55K | 131K | 131K | 54K | 0 | 0 |
Stock-based compensation expense | 3.93M | 2.41M | 4.72M | 2.87M | 3.80M | 1.11M | 966K | 356K | 0 | 0 |
| Deferred income tax benefit | 3.93M | 2.41M | 4.72M | 2.87M | 3.80M | 1.11M | 966K | 356K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 746K | -365K | 2.74M | -3.1M | -692K |
Inventories | 0 | 0 | 0 | 0 | 0 | 1.00M | -472K | 1.95M | -1.84M | -127K |
Accounts payable | 2.61M | 1.05M | -2.46M | 124.97K | 86.41K | 173K | -753K | -585K | 2.92M | 295K |
Cash generated by operating activities | -37.24M | -29.47M | -19.40M | -17.96M | -15.16M | -4.00M | -8.42M | -1.73M | -7.45M | -3.87M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2.84K | -2.50M | -3.18M | -11.93K | -13.94K | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.84K | -2.43M | -3.18M | -11.93K | -13.94K | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 34.5M | 37.14M | 20.70M | 18.13M | 419K | 8.82M | 2.96M | 0 | 3.88M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -58.19K | -2.46M | 0 | -325K | 0 | -1.29M | 0 | -10.33M | -1.17M |
Cash used in financing activities | 19.91M | 41.05M | 55.85M | 16.84M | 20.55M | 2.97M | 9.76M | 1.75M | 7.54M | 3.81M |
Net Change In Cash | -17.33M | 9.14M | 33.25M | -1.13M | 5.37M | -1.02M | 1.33M | 22K | 96K | -61K |
Cash at end of period | 29.65M | 46.99M | 37.85M | 4.59M | 5.72M | 426K | 1.45M | 119K | 97K | 1K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |